Hims & Hers Appoints New CMO, Adds Directors
Ticker: HIMS · Form: 8-K · Filed: Jul 22, 2024 · CIK: 1773751
| Field | Detail |
|---|---|
| Company | Hims & Hers Health, Inc. (HIMS) |
| Form Type | 8-K |
| Filed Date | Jul 22, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.0001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: leadership-change, board-of-directors, executive-appointment
Related Tickers: HIMS
TL;DR
Hims & Hers shakes up leadership: new CMO in, old CMO out, two new board members elected.
AI Summary
Hims & Hers Health, Inc. announced on July 16, 2024, the appointment of Dr. Melissa Byington as Chief Medical Officer and the departure of Dr. Patrick Carroll from the same role. Dr. Byington's appointment is effective immediately, and she will also serve as a member of the company's executive leadership team. The company also announced the election of two new directors, Dr. David Rosenberg and Ms. Sarah McCombie, to its Board of Directors.
Why It Matters
Changes in key executive and board positions can signal shifts in company strategy or operational focus, potentially impacting future performance and investor confidence.
Risk Assessment
Risk Level: medium — Changes in executive and board leadership can introduce uncertainty regarding future strategy and execution.
Key Players & Entities
- Hims & Hers Health, Inc. (company) — Registrant
- Dr. Melissa Byington (person) — Appointed Chief Medical Officer
- Dr. Patrick Carroll (person) — Departed Chief Medical Officer
- Dr. David Rosenberg (person) — Elected Director
- Ms. Sarah McCombie (person) — Elected Director
- July 16, 2024 (date) — Date of earliest event reported
FAQ
Who has been appointed as the new Chief Medical Officer for Hims & Hers Health, Inc.?
Dr. Melissa Byington has been appointed as the new Chief Medical Officer for Hims & Hers Health, Inc.
Who has departed from the role of Chief Medical Officer?
Dr. Patrick Carroll has departed from the role of Chief Medical Officer.
When was the earliest event reported in this 8-K filing?
The earliest event reported in this 8-K filing was on July 16, 2024.
How many new directors were elected to the Board of Directors?
Two new directors, Dr. David Rosenberg and Ms. Sarah McCombie, were elected to the Board of Directors.
What is the exact name of the registrant?
The exact name of the registrant is Hims & Hers Health, Inc.
Filing Stats: 602 words · 2 min read · ~2 pages · Grade level 11.1 · Accepted 2024-07-22 16:35:22
Key Financial Figures
- $0.0001 — which registered Class A Common Stock, $0.0001 par value HIMS New York Stock Exchange
Filing Documents
- hims-20240716.htm (8-K) — 25KB
- 0001773751-24-000230.txt ( ) — 145KB
- hims-20240716.xsd (EX-101.SCH) — 2KB
- hims-20240716_lab.xml (EX-101.LAB) — 21KB
- hims-20240716_pre.xml (EX-101.PRE) — 12KB
- hims-20240716_htm.xml (XML) — 3KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. HIMS & HERS HEALTH, INC. Date: July 22, 2024 By: /s/ Andrew Dudum Andrew Dudum Chief Executive Officer